Chapter 14: Hallucinogens

Categorizing Hallucinogens

  • LSD

  • Mushrooms

  • Mescaline

  • DOM, MDA, MDMA (Ecstasy)

  • PCP

  • Salvia

Animism and Religion

  • Follower of this, who has access to, and influence in, the world of spirits, is known as a Shaman

  • Plants evolved to produce chemicals that alter the biochemistry of animals.

  • Humans discovered that some plants alter perceptions and emotions.

  • Animism: Belief that animals, plants, rocks, and other natural features derive their special characteristics from a spirit contained within the object.

    • Eating a plant transfers its spirit to the consumer, potentially granting special powers or insights.

  • Psychoactive plants have been important in medicine and the development of spiritual/religious traditions.

Terminology

  • Naming this family of drugs is a complex issue.

  • Phantastica: Drugs that create a world of fantasy in our minds

  • Psychedelic: “Mind-viewing,” a term that controversially implies a beneficial, visionary type of effect

  • Psychotomimetic: “Mimicking psychosis”—by producing hallucinations and some altered sense of reality, these drugs produce a state that could be described as psychotic

  • Entheogen: Substances that create spiritual or religious experiences.

  • Entactogen: Substances that enhance feelings of empathy.

  • Hallucinogens: A drug that produces profound alterations in perception, including unusual visual sensations and often changes in the perception of one’s own body.

Classification

  • Hallucinogens can be classified by:

    • Chemical structure

    • Known pharmacological properties

    • How much loss of awareness they cause

    • How dangerous they are

  • Two Major Groups:

    • Classical phantastica: Alter perceptions while allowing the user to remain in communication with the present world.

    • Deliriants: Produce more mental confusion, greater clouding of consciousness, and a loss of touch with reality.

Phantastica: Major Groups

  • Indole Hallucinogens:

    • Drugs that have the indole structure also found in the neurotransmitter serotonin.

    • Examples: LSD, psilocybin.

  • Catechol Hallucinogens:

    • Drugs that have the catechol nucleus that forms the basic structure of the neurotransmitters norepinephrine and dopamine.

    • Examples: mescaline, MDMA (Ecstasy).

Indole Hallucinogens examples

  • d-lyseric acid diethylamide (LSD)

    • (9,10didehydroN,Ndiethyl6methylergoline8bcarboxamide)(9, 10 {didehydro} - N, N- {diethyl} - 6 - {methyl-ergoline} - 8b - {carboxamide})

  • Psilocybin

    • (3[2(dimethylamino)ethyl]indol4oldihydrogenphosphateester)(3-[2-( {dimethylamino}) {ethyl}] - indol-4-ol {dihydrogen phosphate ester})

LSD: Discovery

  • LSD is not found in nature; it is synthesized from alkaloids extracted from the ergot fungus Claviceps purpurea.

    • Eating grain infected with this fungus causes ergotism.

      • During famine, infected grain might be consumed, leading to outbreaks.

      • Associated with Saint Anthony's fire and the 1692 Salem witch trials.

  • 1938: Synthesized by Dr. Albert Hofmann of Sandoz Laboratories in Switzerland.

  • 1943: Dr. Hofmann took a large dose and described its effects.

    • Potency of the drug attracted attention because a very small dose produces effects.

    • Comparable effects from mescaline would require 4,000 times the dose.

LSD: Early Research

  • Between 1953 and 1966, large quantities of LSD were produced for research into several potential uses:

    • In psychotherapy, to help patients bring up repressed memories and motives.

    • As a possible treatment for alcohol dependence.

    • In terminal cancer patients, to help them explore their feelings about their own mortality.

  • Most research on LSD was found to contribute little to our understanding of the effects of the drug.

  • Most research since 1975 has been conducted on animals to understand the drug’s action at the neural level.

LSD: Secret Army/CIA Research

  • 1975 report on the 1953 suicide of a biochemist who had secretly been given LSD by CIA agents.

    • First public exposure of Army/CIA use of LSD.

    • Use of hallucinogens for warfare and for interrogation of prisoners and spies.

  • Army/CIA-sponsored research was poorly done and violated many ethical codes.

    • Participants were not volunteers, could not leave the experiment, and/or were not told the nature of the experiment.

LSD: Recreational Use and Timothy Leary

  • Experiments by psychologist Timothy Leary and Dr. Richard Alpert on Harvard graduate students.

    • Began with proper supervision and controls but were later changed in ways that called into question the scientific validity of the research.

  • 1966: Leary started a religion, the League of Spiritual Discovery, with LSD as the sacrament.

  • 1966: AMA called for greater controls on LSD and other hallucinogens due to the risk of panic and psychosis in some users.

    • Use peaked in 1967 and 1968, then fell due to reports of problems associated with its use.

    • Leary served time in prison on drug charges and later stopped advocating the use of LSD or any drug.

LSD Pharmacology

  • LSD is odorless, colorless, tasteless, and one of the most potent psychochemicals known.

  • No known human overdose deaths.

    • LD50LD_{50} is about 400 times the behaviorally effective dose.

  • Absorbed rapidly through the gastrointestinal tract.

  • LSD is usually taken orally.

  • Half-life is about three hours.

  • LSD is metabolized by the liver.

  • Excreted as the inactive chemical 2-oxy-lysergic acid diethylamide.

  • Tolerance develops rapidly, within three to four days of daily doses.

    • Recovery from tolerance is also rapid.

    • Cross-tolerance occurs among LSD, mescaline, and psilocybin.

  • Physical dependence to LSD or other hallucinogens has not been shown.

  • LSD is a sympathomimetic agent.

    • Autonomic signs appear quickly following administration: dilated pupils, elevated temperature and blood pressure, increased salivation.

  • Indole structure of LSD resembles that of serotonin, implying that LSD works by acting at serotonin receptors.

    • Effects are complex due to the number of, and variation among, subtypes of serotonin receptors and LSD’s different effects on them.

    • Best evidence indicates that LSD acts by stimulating the serotonin-2A subtype of receptor.

The LSD Experience

  • Modification of perceptions.

    • Visual images: Users see shapes and patterns, usually with intense colors and brightness.

    • Users report an altered sense of time, changes in the perception of their own bodies, and alterations of auditory input.

    • Synesthesia (“mixing of senses”), in which sounds may appear as visual images or visual pictures might alter in rhythm with music.

  • Enhanced emotionality.

    • Images may be perceived as beautiful and awe-inspiring or as intensely sad or frightening.

The LSD Experience: “Trips”

  • Typically last six to nine hours.

    • Autonomic responses occur over the first 20 minutes.

    • Alterations in mood, perception, and sensation begin in the next 30 to 40 minutes.

    • Full intoxication occurs within one hour.

    • Loss of self-awareness and loss of control of behavior may occur.

  • Unique and variable experiences.

    • Expansive and pleasant—user feels she or he is uncovering great secrets or profundities.

    • Constricted and negative—user experiences paranoia and feelings of persecution.

  • Form-constants

    • May be combined with complex images

  • Synesthesia

    • Mixing of senses

  • Each trip is a unique experience

  • Impact on creativity

    • Unlikely to be enhanced successfully

  • Therapeutic usefulness?

LSD: Adverse Reactions

  • Impossible to determine true incidence of adverse reactions.

    • Some bad reactions may be due to impurities in street LSD and/or preexisting psychological conditions in the user.

  • Panic reactions.

  • Flashbacks

    • Recurrence of symptoms weeks or months after an individual has taken LSD.

    • Rare, variable, and unpredictable in occurrence.

    • DSM-5 classifies them as Hallucinogen Persisting Perception Disorder.

Psilocybin: “Magic Mushrooms”

  • Long history of use among natives of Mexico.

    • Psilocybe mexicana is the most well-known psychoactive mushroom.

    • Primary active ingredient is the indole psilocybin.

      • Dried mushrooms are 0.2 to 0.5 percent psilocybin.

  • Effects are similar to LSD and mescaline, and cross-tolerance exists among the three.

    • Effects depend on dose.

      • Up to 4 mg causes relaxation and some body sensations.

      • Higher doses cause perceptual and body-image changes, with hallucinations in some individuals.

  • Sympathetic arousal symptoms.

  • May only be active after converted to psilocin

Psilocybin

  • Good Friday study (1962) by one of Timothy Leary’s followers.

    • Seminary students were given psilocybin or a placebo 90 minutes before attending a religious service.

    • Study looked at the effect and magnitude of changes caused by the drug and at the durability of the changes.

    • Researchers concluded that under certain circumstances, the drug enhances mystical or religious experiences.

  • Most current production is from local, amateur growers.

    • “Shrooms” might be consumed at a party in combination with alcohol.

Peyote

  • Peyote (from the Aztec peyotl) is a small, spineless, carrot-shaped cactus, Lophophora williamsii Lemaire.

    • Mostly subterranean, with only the pincushion-like top appearing above ground.

    • Long pre-Columbian history of use among Mexican Indians, who used the plant ceremonially.

  • Upper portion (crown) is sliced into disks and dried, creating so-called mescal buttons

    • Not the same as mescal beans or mescal liquor

      • Mescal beans may produce some hallucinogenic effects but are highly toxic

    • Dried buttons remain psychoactive indefinitely

    • Mescaline is the primary active agent

    • Peyote cult moved north and became widely established among Indians of the plains by the late 19th century

    • Native American Church is an amalgamation of Christianity and traditional beliefs and practices of Native Americans, with peyote use incorporated into its ceremonies

Peyote and Mescaline Use

  • Peyote use:

    • In religious ceremonies

    • As a treatment for illness

    • Worn as a protective amulet

    • Current laws governing the use of peyote as a sacrament vary from state to state

  • Mescaline was isolated and synthesized by 1918.

    • Peyote includes many other psychoactive alkaloids, but mescaline has been identified as primarily responsible for the visual effects.

    • Users may experience bad trips as well as nausea and physical discomfort.

    • San Pedro cactus: Another mescaline-containing cactus, Trichocereus pachanoi, has also been used for thousands of years, but its recreational use is limited by frequent adverse side effects.

Mescaline: Pharmacology

  • Rapidly absorbed if taken orally.

  • Half-life is about 6 hours.

  • Effects:

    • Low dose effects are primarily euphoric.

    • Higher doses cause the full set of hallucinogenic effects.

  • Most mescaline is excreted unchanged.

  • Psychoeffective dose causes sympathetic arousal.

  • LD50LD_{50} is about 10 to 30 times the dose needed to cause behavioral effects.

  • Tolerance develops more slowly to mescaline than to LSD.

  • Cross-tolerance between LSD and mescaline.

Amphetamine Derivatives

  • A group of synthetic hallucinogens.

    • Chemically related to amphetamines.

    • Due to chemical structure, they have few stimulant effects and act much more like mescaline.

    • Examples:

      • DOM

      • MDA and other “designer drugs”

      • MDMA (Ecstasy).

DOM and MDA

  • DOM:

    • 2,5-dimethoxy-4-methylamphetamine

    • Earlier street name was STP (“serenity, tranquility, peace”).

    • Effects similar to mescaline and LSD.

  • MDA and others:

    • Group includes “designer drugs” that are not all specifically listed as controlled substances.

MDMA: “Ecstasy”

  • Similar in structure to MDA but acts differently.

  • Prior to the scheduling of MDMA, some psychiatrists used it in practice because it was viewed as having a special ability to promote empathy, aiding in therapy.

  • Effects:

    • Heightened sense of “closeness” with others.

    • Increased heart rate and blood pressure.

    • Euphoria and increased sociability.

    • Other autonomic effects.

  • Some research has found that MDMA may cause brain damage.

    • Selective destruction of serotonin neurons.

    • Strong evidence from animal studies but limited evidence of long-term neurotoxic effects in humans.

  • Listed as a Schedule I drug but continues to be studied as a potential psychotherapeutic agent.

  • 3,4 methylenedioxymeth- amphetamine § a stimulant and psychedelic

  • Taken in tablet form

  • Chemically similar to methamphetamines

  • Some caveats about MDMA research…

MDMA (Ecstasy) Short Term Effects

  • Feelings of mental stimulation

  • Emotional warmth

  • General sense of well being

  • Decreased anxiety

  • Enhanced sensory perception

  • From: National Institute on Drug Abuse Research Report (2006)

MDMA (Ecstasy): Undesirable Effects

  • Anxiety

  • Restlessness

  • Irritability

  • Sadness

  • Impulsiveness

  • Aggression

  • Sleep disturbances

  • Lack of appetite

  • Reduced interest in and pleasure from sex

  • From: National Institute on Drug Abuse Research Report (2006)

MDMA (Ecstasy): Health Effects

  • Nausea

  • Chills

  • Sweating

  • Involuntary teeth clenching

  • Muscle cramping

  • Blurred vision

  • Overdose:

    • High blood pressure

    • Faintness

    • Panic attacks

    • Loss of consciousness and seizures

  • From:National Institute on Drug Abuse Research Report (2006)

MDMA and the Brain

  • Compared to meth:

    • causes greater serotonin release

    • somewhat lesser dopamine release

  • Monkey studies suggest that MDMA destroys serotonergic neurons (Hatzidimitriou et al, 1999)

Deliriants

  • Compared to “phantastica,” deliriants tend to produce more mental confusion and a loss of touch with reality.

  • Deliriants act through a number of different brain mechanisms.

PCP (Phencyclidine)

  • 1-(1-phenylcyclohexyl) piperidine hydrochloride

  • Initially appeared to be a good anesthetic.

    • It does not depress blood circulation or respiration or produce heart rate irregularities as some anesthetics do.

  • Mechanism of action of PCP

    • PCP alters many neurotransmitter systems

    • Sigma receptor may be selective for PCP and similar drugs

  • Effects: Reactions to the drug were found to be unpredictable.

    • Some patients experienced changes in body perception, hallucinations, and prolonged confusion.

    • Some patients became angry, uncooperative, or unmanageably manic.

    • Most users experienced diminished pain, touch, and position sense, as well as nystagmus.

    • Overall, PCP causes a dissociative state that resembles schizophrenia much more than the LSD state.

  • By 1960, PCP had been characterized as:

    • An excellent anesthetic for monkeys

    • A medically safe but psychologically troublesome anesthetic for humans

    • A hallucinogen different from LSD and mescaline, with profound effects on body perception

  • Currently, PCP is licensed for use as an animal anesthetic

PCP: Recreational Use

  • Has had brief, sporadic periods of popularity.

    • Relatively inexpensive and easy to manufacture.

    • Sprinkled onto oregano, parsley, or alfalfa and sold as marijuana.

      • Called “angel dust.”

    • Joints made with PCP containing marijuana or another plant substance.

      • Called “killer joints” or “sherms.”

  • Some users develop psychological dependence on PCP.

    • Animal studies also indicate a dependence-producing potential.

    • A few but not all PCP users have been reported to behave violently.

    • Urban legends of superhuman strength among PCP users are most likely false, BUT

    • Police attempting to arrest PCP users have had trouble subduing them due to the anesthetic effects of PCP.

Salvia Divinorum (“Diviner’s Sage”)

  • Used for centuries in Oaxaca, Mexico, in religious ceremonies.

  • Traditional methods of use:

    • Chewing the leaves

    • Drinking a tea made from the crushed leaves

    • Smoking the dried leaves

  • Produces a hallucinatory effect

    • Recreational use reported in Mexico and the U.S.

    • Not currently listed as a federally controlled substance in the U.S. but is outlawed in several states.

  • Mechanism of action:

    • Active ingredient is salvinorin A, a highly potent agent.

    • Salvinorin A binds selectively to the kappa opioid receptor, acting as an agonist (a unique pharmacological effect).

New Research on Hallucinogens as Therapeutic Agents

  • Psilocybin research on terminal patients

  • MDMA research on PTSD and trauma

  • LSD research on terminal patients and fear of death